Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503086 · ClinicalTrials.gov registry record · NA
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
A NA study of Brain Neoplasm and Recurrent Brain Neoplasm, sponsored by Children's Oncology Group.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 20
- Study locations
NCT01503086: Active NA study of Brain Neoplasm and Recurrent Brain Neoplasm, sponsored by Children's Oncology Group.
NCT01503086 is a NA study of Brain Neoplasm and Recurrent Brain Neoplasm that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 45 participants, roughly in line with the 49-participant average among 9 other Brain Neoplasm trials with a reported enrollment target. The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01503086, a NA study of Brain Neoplasm and Recurrent Brain Neoplasm, is active but no longer recruiting, sponsored by Children's Oncology Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 20
- Study locations
Study Summary
This randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer training program may improve the well-being and quality of life of patients with cognitive (physical and mental) function difficulties caused by radiation therapy to the brain.
Primary Outcome
Intervention compliance is defined as at least 80% of computerized training sessions completed (i.e., completing at least 20 sessions within 9 weeks of starting training). Will report the proportion of eligible, randomized patients who meet the compliance definition by arm with corresponding 95% confidence intervals.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- PROCEDURE Cognitive Assessment
- OTHER Computer-Assisted Cognitive Training
- PROCEDURE Psychosocial Assessment and Care
Study Locations (20)
Florida
- Broward Health Medical Center - Fort Lauderdale
- Golisano Children's Hospital of Southwest Florida - Fort Myers
- Nemours Children's Clinic-Jacksonville - Jacksonville
- Nemours Children's Hospital - Orlando
- Tampa General Hospital - Tampa
Missouri
- Children's Mercy Hospitals and Clinics - Kansas City
- Washington University School of Medicine - St Louis
North Carolina
- Duke University Medical Center - Durham
- Wake Forest University Health Sciences - Winston-Salem
Colorado
- Children's Hospital Colorado - Aurora
Delaware
- Alfred I duPont Hospital for Children - Wilmington
District of Columbia
- Children's National Medical Center - Washington D.C.
Georgia
- Children's Healthcare of Atlanta - Arthur M Blank Hospital - Atlanta
Idaho
- Saint Luke's Cancer Institute - Boise - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-07-30 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT01503086 still lists
NCT01503086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, roughly in line with the 49-participant average among 9 other Brain Neoplasm trials with a reported enrollment target.
The record links to 2 conditions, with Brain Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01503086 names 20 study sites across 14 states, led by Florida, Missouri, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01503086 about?
NCT01503086 is a clinical study titled "Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy". This randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer training program may improv...
What is the current status of trial NCT01503086?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2014-07-30. Estimated completion is 2026-03-31.
What conditions does trial NCT01503086 study?
This clinical trial studies the following conditions: Brain Neoplasm, Recurrent Brain Neoplasm.
What interventions are being tested in trial NCT01503086?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Cognitive Assessment (PROCEDURE), Computer-Assisted Cognitive Training (OTHER), Psychosocial Assessment and Care (PROCEDURE).
Who is sponsoring clinical trial NCT01503086?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01503086 being conducted?
This trial has 20 study locations across Colorado, Delaware, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01503086's enrollment target sits among peer trials
45 4th of 9 higher than 6 of 9 other Brain Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
RECRUITING · NA
-
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors
ACTIVE NOT RECRUITING · NA
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
Tumor Related Epilepsy
RECRUITING
-
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
RECRUITING · Phase 2
-
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI